SUBSCRIBE
SUBSCRIBE

Neon Therapeutics

NEWS
Neon Therapeutics was acquired by BioNTech in 2020.
Investor
Deals
Denali Raises a Mountain of Cash
A look at what three ex-Genentech employees have accomplished at Denali so far.
December 12, 2017
 · 
1 min read
Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million
Genetown
Massachusetts Startup Neon Therapeutics Rakes in $70 Million for Personalized Cancer Vaccines
January 5, 2017
 · 
2 min read
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Neon Therapeutics
Business
What You Need to Know About Neon Therapeutics
January 3, 2017
 · 
3 min read
Neon Therapeutics Taps Former Novartis AG Cancer Vet as New CEO
Business
Neon Therapeutics Taps Former Novartis AG Cancer Vet as New CEO
September 27, 2016
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2017
IN THE PRESS
Deals
BioNTech Completes Acquisition of Neon Therapeutics
May 6, 2020
 · 
3 min read
Drug Development
Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01Phase 1 Clinical Trial of Personal Neoantigen-Targeted T Cell Therapy Expected to Initiate in Third Quarter 2020
April 30, 2020
 · 
5 min read
Policy
SHAREHOLDER ALERT: WeissLaw LLP Investigates Neon Therapeutics, Inc.
April 10, 2020
 · 
2 min read
Business
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
March 2, 2020
 · 
10 min read
Genetown
Neon Therapeutics Submits European Clinical Trial Authorization Application for Personal Neoantigen-Targeted T Cell Therapy NEO-PTC-01Study of NEO-PTC-01 in metastatic melanoma patients expected to initiate in first half of 2020
December 18, 2019
 · 
5 min read
Genetown
Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs
November 20, 2019
 · 
8 min read
Business
Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent HighlightsRecent Progress Achieved Across RECON® Bioinformatics Platform and Lead Neoantigen-Targeted Immunotherapy Programs
November 12, 2019
 · 
8 min read
Genetown
Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 8, 2019
 · 
8 min read
Genetown
Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine
October 18, 2018
 · 
8 min read
Genetown
Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 CongressCompany to Host Investor Conference Call and Webcast on October 22, 2018 at 8:00 a.m. ET
October 3, 2018
 · 
4 min read
Load More